Bracco Diagnostics multihance (gadobenate dimeglumine) injection, 529 mg/mL, 20ml, Rx only, Manuf...

FDA Drug Recall #D-1663-2012 — Class III — April 16, 2012

Recall Summary

Recall Number D-1663-2012
Classification Class III — Low risk
Date Initiated April 16, 2012
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Bracco Diagnostics Inc
Location Monroe Township, NJ
Product Type Drugs
Quantity 47,750 vials

Product Description

Bracco Diagnostics multihance (gadobenate dimeglumine) injection, 529 mg/mL, 20ml, Rx only, Manufactured for: Bracco Diagnostics Inc., Princeton, NJ 08543 USA, NDC 0270-5164-15

Reason for Recall

Short Fill: The product is being recalled due to a potential underfill of the affected vials.

Distribution Pattern

Nationwide

Lot / Code Information

Lot S1P272A Expiry Date: December 2014

Other Recalls from Bracco Diagnostics Inc

Recall # Classification Product Date
D-1083-2014 Class III VoLumen Barium Sulfate Suspension (0.1 % w/v, 0... Dec 16, 2013
D-914-2013 Class III Tagitol V Barium Sulfate Suspension (40% w/v, 3... Jul 19, 2013
D-885-2013 Class II Gastrografin (Diatrizoate Meglumine and Diatriz... Jun 21, 2013
D-1684-2012 Class II CARDIOGEN-82 (Rubidium Rb 82 Generator), 140 mi... Jun 1, 2012
D-1665-2012 Class II Multihance Multipack (gadobenate dimeglumine) i... Apr 16, 2012

Frequently Asked Questions

Stop taking the medication and contact your pharmacist or doctor immediately. For Class I recalls, this is urgent. For Class II or III recalls, consult your doctor before stopping — abruptly discontinuing certain medications (blood pressure drugs, antidepressants, diabetes medications) can be more harmful than continuing while arranging a replacement. Check whether the recall applies to your specific lot number and expiration date. Return the product to your pharmacy and report any adverse effects to FDA MedWatch at 1-800-FDA-1088.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.